Biomerica (BMRA) Change in Receivables (2010 - 2026)
Biomerica's (BMRA) quarterly Change in Receivables came in at -$64000.0 in Q1 2026, down 6.67% year-on-year from -$68571.4 in Q1 2025, and up 71.81% quarter-over-quarter from -$227000.0 in Q4 2025.
Biomerica (BMRA) Change in Receivables (2010 - 2026) Analysis & Trends
Biomerica has disclosed Change in Receivables across 17 years of filings, most recently posting -$64000.0 for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$64000.0, down 6.67% year-over-year; the trailing twelve-month figure through Feb 2026 was -$315000.0 (down 325.0% YoY), and the FY2025 annual result was -$209000.0, down 197.21% from the prior year.
- Change in Receivables came in at -$64000.0 for Q1 2026 at Biomerica, up from -$227000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $708000.0 in Q3 2023 to a low of -$536000.0 in Q2 2025.
- The 5-year median for Change in Receivables is $26015.0 (2022), against an average of $79850.0.
- Peak annual rise in Change in Receivables reached 1687.43% in 2023, while the deepest fall reached 749.12% in 2023.
- Biomerica's Change in Receivables stood at $57000.0 in 2022, then sank by 749.12% to -$370000.0 in 2023, then jumped by 38.11% to -$229000.0 in 2024, then increased by 0.87% to -$227000.0 in 2025, then jumped by 71.81% to -$64000.0 in 2026.
- The last three Change in Receivables figures came in at -$64000.0 (Q1 2026), -$227000.0 (Q4 2025), and $512000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 | -64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -64,000.00 |
| Feb 28, 2026 | -64,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Aug 31, 2025 | 512,000.00 |
| Aug 31, 2025 | 512,000.00 |
| May 31, 2025 | -536,000.00 |
| May 31, 2025 | -536,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Aug 31, 2024 | 616,000.00 |
| Aug 31, 2024 | 616,000.00 |
| May 31, 2024 | -187,000.00 |
| May 31, 2024 | -187,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Nov 30, 2023 | -370,000.00 |
| Nov 30, 2023 | -370,000.00 |